Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in mexican americans

Diabetes

Volumn 57, Issue 4, 2008, Pages 1048-1056

  Black, Mary Helen ^a   Fingerlin, Tasha E ^b   Allayee, Hooman ^a   Zhang, Weiming ^b   Xiang, Anny H ^a   Trigo, Enrique ^a   Hartiala, Jaana ^a   Lehtinen, Allison B ^c   Haffner, Steven M ^d   Bergman, Richard N ^a   McEachin, Richard C ^e   Kjos, Siri L ^f   Lawrence, Jean M ^g   Buchanan, Thomas A ^a   Watanabe, Richard M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d Mays Cancer Center at UT Health San Antonio   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f HARBOR UCLA MEDICAL CENTER   (United States)

^g KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; HEPATOCYTE NUCLEAR FACTOR 4; HNF4A PROTEIN, HUMAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HISPANIC; HOMOZYGOTE; HUMAN; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE TRAIT; SINGLE NUCLEOTIDE POLYMORPHISM; AMINO ACID SUBSTITUTION; GENETICS; METABOLISM; PHYSIOLOGY; PREGNANCY; RISK FACTOR; SIBLING; UNITED STATES;

AMINO ACID SUBSTITUTION; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; HEPATOCYTE NUCLEAR FACTOR 4; HISPANIC AMERICANS; HUMANS; INSULIN; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; PREGNANCY; PROMOTER REGIONS (GENETICS); RISK FACTORS; SAN FRANCISCO; SIBLINGS; TEXAS; VARIATION (GENETICS);

EID: 42449130081     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-0848     Document Type: Article

References (44)

1. Buchanan TA, Metzger BE, Freinkel N, Bergman RN: Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 162:1008-1014, 1990
2. Kjos SL, Peters RK, Xiang A, Henry OA, Montoro M, Buchanan TA: Predicting future diabetes in Latino women with gestational diabetes. Diabetes 44:586-591, 1995
3. Kautzky-Willer A, Prager R, Waldhausl W, Pacini G, Thomaseth K, Wagner OF, Ulm M, Streli C, Ludvik B: Pronounced insulin resistance and inadequate β-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care 20:1717-1723, 1997
4. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Tan S, Berkowitz K, Hodis HN, Azen SP: Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51:2796-2803, 2002
5. Watanabe RM, Xiang A, Trigo E, Hernandez S, Berrios F, Langefeld C, Kjos S, Ouzunian J, Sacks D, Lawrence J, Buchanan T: Evidence of genetic predisposition for B-cell dysfunction in Mexican-American families of probands with gestational diabetes (Abstract). Diabetes 52:A257, 2003
6. Bergman RN, Zaccaro DJ, Watanabe RM, Haffner SM, Saad MF, Norris JM, Wagenknecht LE, Hokason JE, Rotter JI, Rich SS: Minimal model-based insulin sensitivity has greater heritability and a different genetic basis than homeostasis model assessment or fasting insulin. Diabetes 52:2168-2174, 2003
7. Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefebvre AM, Saladin R, Najib J, Laville M, Fruchart JC, Deeb S, Vidal-Puig A, Flier J, Briggs MR, Staels B, Vidal H, Auwerx J: The organization, promoter analysis, and expression of the human PPARy gene. J Biol Chem 272:18779-18789, 1997
8. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W: Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α,-β, and-γ in the adult rat. Endocrinology 137:354-366, 1996
9. Deeb SS, Fajas L, Nemoto M, Pihlajamäki J, Laakso M, Fujimoto W, Auwerx J: A Pro12Ala substitution in PPARy2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284-287, 1998
10. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl M-C, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES: The common PPARy Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76-80, 2000
11. Cole SA, Mitchell BD, Hsueh W-C, Pineda P, Beamer BA, Shuldiner AR, Comuzzie AG, Blangero J, Hixson JE: The Pro12Ala variant of peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) is associated with measures of obesity in Mexican Americans. Int J Obes 24:522-524, 2000
12. Douglas JA, Erdos MR, Watanabe RM, Braun A, Johnston CL, Oeth P, Mohlke KL, Valle TT, Ehnholm C, Buchanan TA, Bergman RN, Collins FS, Boehnke M, Tuomilehto J: The peroxisome proliferator-activated recep-tor-γ2 Pro12Ala variant: association with type 2 diabetes and trait differences. Diabetes 50:886-890, 2001
13. Hsueh W-C, Cole SA, Shuldiner AR, Beamer BA, Blangero J, Hixson JE, MacCluer JW, Mitchell BD: Interactions between variants in the p3-adrenergic receptor and peroxisome proliferator-activated receptor-γ2 genes and obesity. Diabetes Care 24:672-677, 2001
14. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK, Fraenkel E, Bell GI, Young RA: Control of pancreas and liver gene expression by HNF transcription factors. Science 303:1378-1381, 2004
15. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Steffel M, Bell GI: Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature 384:458-460, 1996
16. Silander K, Mohlke KL, Scott LJ, Peck EC, Hollstein P, Skol AD, Jackson AU, Deloukas P, Hunt S, Stavrides G, Chines PS, Erdos MR, Narisu N, Conneely KN, Li C, Fingerlin TE, Dhanjal SK, Valle TT, Bergman RN, Tuomilehto J, Watanabe RM, Boehnke M, Collins FS: Genetic variation near the hepatocyte nuclear factor-4α gene predicts susceptibility to type 2 diabetes. Diabetes 53:1141-1149, 2004
17. Love-Gregory LD, Wasson J, Ma J, Jin CH, Glaser B, Suarez BK, Permutt MA: A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4α gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an Ashkenazi Jewish population. Diabetes 53:1134-1140, 2004
18. Damcott CM, Hoppman N, Ott SH, Reinhart LJ, Wang J, Pollin TI, O'Connell JR, Mitchell BD, Shuldiner AR: Polymorphisms in both promoters of hepatocyte nuclear factor 4-α are associated with type 2 diabetes in the Amish. Diabetes 53:3337-3341, 2004
19. Hansen SK, Rose CS, Glumer C, Drivsholm T, Borch-Johnsen K, J0rgensen T, Pedersen O, Hansen T: Variation near the hepatocyte nuclear factor (HNF)-4α gene associates with type 2 diabetes in the Danish population. Diabetologia 48:452-458, 2005
20. Bagwell AM, Bento JL, Mychaleckyj JC, Freedman BI, Langefeld CD, Bowden DW: Genetic analysis of HNF4A polymorphisms in Caucasian-American type 2 diabetes. Diabetes 54:1185-1190, 2005
21. Winckler W, Graham RR, de Bakker PIW, Sun M, Almgren P, Tuomi T, Gaudet D, Hudson TJ, Ardlie KG, Daly MJ, Hirschhorn JN, Groop L, Altshuler D: Association testing of variants in the hepatocyte nuclear factor 4α gene with risk of type 2 diabetes in 7,883 people. Diabetes 54:886-892, 2005
22. Henkin L, Bergman RN, Bowden DW, Ellsworth DL, Haffner SM, Langefeld CD, Mitchell BD, Norris JM, Rewers M, Saad MF, Stamm E, Wagenknecht LE, Rich SS: Genetic epidemiology of insulin resistance and visceral adiposity: the IRAS family study design and methods. Am J Epidemiol 13:211-217, 2003
23. Wagenknecht LE, Mayer EJ, Rewers M, Haffner S, Selby J, Borok GM, Henkin L, Howard G, Savage PJ, Saad MF, Bergman RN, Hamman R: The Insulin Resistance Atherosclerosis Study (IRAS) objectives, design, and recruitment results. Ann Epidemiol 5:464-472, 1995
24. Herbert V, Law K, Gottlieb C, Bleicher S: Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375-1384, 1965
25. Livak KJ: SNP genotyping by the 5'-nuclease reaction. Methods Mol Biol 212:129-147, 2003
26. Beutow KH, Edmonson M, MacDonald R, Clifford R, Yip P, Kelley J, Little DP, Strausberg R, Koester H, Cantor CR, Braun A: High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad SciUSA 98:581-584, 2001
27. Bergman RN, Phillips LS, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456-1467, 1981
28. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265, 2005
29. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D: The structure of haplotype blocks in the human genome. Science 296:2225-2229, 2002
30. Shetterly SM, Bater J, Morgenstern NE, Grigsby J, Hamman RF: Higher instrumental activities of daily living disability in Hispanics compared with non-Hispanic Whites in rual Colorado. Am J Epidemiol 147:1019-1027, 1998
31. Bonilla C, Parra EJ, Pfaff CL, Dios S, Marshall JA, Hamman RF, Ferrell RE, Hoggart CL, McKeigue PM, Shriver MD: Admixture in the Hispanics of the San Luis Valley, Colorado, and its implications for complex trait gene mapping. Ann Intern Med 68:139-153, 2004
32. Price AL, Patterson N, Yu F, Cox DR, Waliszewska A, McDonald GJ,Tandon A, Schirmer C, Neubauer J, Bedoya G, Duque C, Villegas A, Bortolini MC, Salzano FM, Gallo C, Mazzotti G, Tello-Ruiz M, Riba L, Aguilar-Salinas CA, Canizales-Quinteros S, Menjivar M, Klitz W, Henderson B, Haiman CA, Winkler C, Tusie-Luna T, Ruiz-Linares A, Reich D: A genomewide admixture map for Latino populations. Am, J Hum, Genet 80:1024-1036, 2007
33. Allard MW, Polanskey D, Wilson MR, Monson KL, Budowle B: Evaluation of variation in control region sequences for Hispanic individuals in the SWGDAM mtDNA data set. J Forensic Sci 51:566-573, 2006
34. Auwerx J: PPARγ, the ultimate thrifty gene. Diabetologia 42:1033-1049, 1999
35. Thomas H, Jaschkowitz K, Bulman M, Frayling TM, Mitchell SMS, Roosen S, Lingott-Frieg A, Tack CJ, Ellard S, Ryffel GU, Hattersley AT: A distant upstream promoter of the HNF-α gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum, Mol Genet 10:2089-2097, 2001
36. Gavrilova O, Haluzik M, Matsusue K, Cutson JJ, Johnson L, Dietz KR, Nicol CJ, Vinson C, Gonzalez FJ, Reitman MI: Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem 278:34268-34276, 2003
37. Schadinger SE, Rucher NLR, Schreiber BM, Farmer SR: PPARγ2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am J Physiol 288:E1195-E1205, 2005
38. Luyckx FH, Lefebvre PJ, Scheen AJ: Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabete Metab 26:98-106, 2000
39. Stumvoll M, Wahl HG, Loblein K, Becker R, Machicao F, Jacob S, Haring H: Pro12Ala polymorphism in the peroxisome proliferator-activated recep-tor-γ2 gene is associated with increased antilipolytic insulin sensitivity. Diabetes 50:876-881, 2001
40. Rebrin K, Steil GM, Mittelman SD, Bergman RN: Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest 98:741-749, 1996
41. Sheena V, Hertz R, Berman I, Nousbeck J, Bar-Tana J: Transcriptional suppression of human microsomal triglyceride transfer protein by hypo-lipidemic insulin sensitizers. Biochem Pharmacol 70:1548-1559, 2005
42. Sheena V, Hertz R, Nousbeck J, Berman I, Magenheim J, Bar-Tana J: Transcriptional regulation of human microsomal triglyceride transfer protein by hepatocyte nuclear factor-4α. J Lipid Res 46:328-341, 2005
43. Phillips C, Mullan K, Owens D, Tomkin GH: Intestinal microsomal triglyc-eride transfer protein in type 2 diabetic and non-diabetic subjects: the relationship to triglyceride-rich postprandial lipoprotein composition. Atherosclerosis 187:57-64, 2006
44. Rubin D, Helwig U, Pfeuffer M, Schreiber S, Boeing H, Fisher E, Pfeiffer A, Freitag-Wolf S, Foelsch UR, Doering F, Schrezenmeir J: A common functional exon polymorphism in the microsomal triglyceride transfer protein gene is associated with type 2 diabetes, impaired glucose metabolism, and insulin levels. J Hum Genet 51:567-574, 2006